Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma

Uterine carcinosarcoma (UCS) is a highly invasive malignant tumor that originated from the uterine epithelium. Many studies suggested that the abnormal changes of alternative splicing (AS) of pre-mRNA are related to the occurrence and metastasis of the tumor. This study investigates the mechanism of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hongjun Guo, Siqiao Wang, Aiqing Xie, Wenhuizi Sun, Chenlu Wei, Shuyuan Xian, Huabin Yin, Mingxiao Li, Hanlin Sun, Hong Li, Tong Meng, Jie Zhang, Zongqiang Huang
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/41a780605a324a9a8e54100709e540d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:41a780605a324a9a8e54100709e540d9
record_format dspace
spelling oai:doaj.org-article:41a780605a324a9a8e54100709e540d92021-11-08T02:37:24ZRal GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma1875-863010.1155/2021/1484227https://doaj.org/article/41a780605a324a9a8e54100709e540d92021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/1484227https://doaj.org/toc/1875-8630Uterine carcinosarcoma (UCS) is a highly invasive malignant tumor that originated from the uterine epithelium. Many studies suggested that the abnormal changes of alternative splicing (AS) of pre-mRNA are related to the occurrence and metastasis of the tumor. This study investigates the mechanism of alternative splicing events (ASEs) in the tumorigenesis and metastasis of UCS. RNA-seq of UCS samples and alternative splicing event (ASE) data of UCS samples were downloaded from The Cancer Genome Atlas (TCGA) and TCGASpliceSeq databases, several times. Firstly, we performed the Cox regression analysis to identify the overall survival-related alternative splicing events (OSRASEs). Secondly, a multivariate model was applied to approach the prognostic values of the risk score. Afterwards, a coexpressed network between splicing factors (SFs) and OSRASEs was constructed. In order to explore the relationship between the potential prognostic signaling pathways and OSRASEs, we fabricated a network between these pathways and OSRASEs. Finally, validations from multidimension platforms were used to explain the results unambiguously. 1,040 OSRASEs were identified by Cox regression. Then, 6 OSRASEs were incorporated in a multivariable model by Lasso regression. The area under the curve (AUC) of the receiver operator characteristic (ROC) curve was 0.957. The risk score rendered from the multivariate model was corroborated to be an independent prognostic factor (P<0.001). In the network of SFs and ASEs, junction plakoglobin (JUP) noteworthily regulated RALGPS1-87608-AT (P<0.001, R=0.455). Additionally, RALGPS1-87608-AT (P=0.006) showed a prominent relationship with distant metastasis. KEGG pathways related to prognosis of UCS were selected by gene set variation analysis (GSVA). The pyrimidine metabolism (P<0.001, R=−0.470) was the key pathway coexpressed with RALGPS1. We considered that aberrant JUP significantly regulated RALGPS1-87608-AT and the pyrimidine metabolism pathway might play a significant part in the metastasis and prognosis of UCS.Hongjun GuoSiqiao WangAiqing XieWenhuizi SunChenlu WeiShuyuan XianHuabin YinMingxiao LiHanlin SunHong LiTong MengJie ZhangZongqiang HuangHindawi LimitedarticleMedicine (General)R5-920ENDisease Markers, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Hongjun Guo
Siqiao Wang
Aiqing Xie
Wenhuizi Sun
Chenlu Wei
Shuyuan Xian
Huabin Yin
Mingxiao Li
Hanlin Sun
Hong Li
Tong Meng
Jie Zhang
Zongqiang Huang
Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma
description Uterine carcinosarcoma (UCS) is a highly invasive malignant tumor that originated from the uterine epithelium. Many studies suggested that the abnormal changes of alternative splicing (AS) of pre-mRNA are related to the occurrence and metastasis of the tumor. This study investigates the mechanism of alternative splicing events (ASEs) in the tumorigenesis and metastasis of UCS. RNA-seq of UCS samples and alternative splicing event (ASE) data of UCS samples were downloaded from The Cancer Genome Atlas (TCGA) and TCGASpliceSeq databases, several times. Firstly, we performed the Cox regression analysis to identify the overall survival-related alternative splicing events (OSRASEs). Secondly, a multivariate model was applied to approach the prognostic values of the risk score. Afterwards, a coexpressed network between splicing factors (SFs) and OSRASEs was constructed. In order to explore the relationship between the potential prognostic signaling pathways and OSRASEs, we fabricated a network between these pathways and OSRASEs. Finally, validations from multidimension platforms were used to explain the results unambiguously. 1,040 OSRASEs were identified by Cox regression. Then, 6 OSRASEs were incorporated in a multivariable model by Lasso regression. The area under the curve (AUC) of the receiver operator characteristic (ROC) curve was 0.957. The risk score rendered from the multivariate model was corroborated to be an independent prognostic factor (P<0.001). In the network of SFs and ASEs, junction plakoglobin (JUP) noteworthily regulated RALGPS1-87608-AT (P<0.001, R=0.455). Additionally, RALGPS1-87608-AT (P=0.006) showed a prominent relationship with distant metastasis. KEGG pathways related to prognosis of UCS were selected by gene set variation analysis (GSVA). The pyrimidine metabolism (P<0.001, R=−0.470) was the key pathway coexpressed with RALGPS1. We considered that aberrant JUP significantly regulated RALGPS1-87608-AT and the pyrimidine metabolism pathway might play a significant part in the metastasis and prognosis of UCS.
format article
author Hongjun Guo
Siqiao Wang
Aiqing Xie
Wenhuizi Sun
Chenlu Wei
Shuyuan Xian
Huabin Yin
Mingxiao Li
Hanlin Sun
Hong Li
Tong Meng
Jie Zhang
Zongqiang Huang
author_facet Hongjun Guo
Siqiao Wang
Aiqing Xie
Wenhuizi Sun
Chenlu Wei
Shuyuan Xian
Huabin Yin
Mingxiao Li
Hanlin Sun
Hong Li
Tong Meng
Jie Zhang
Zongqiang Huang
author_sort Hongjun Guo
title Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma
title_short Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma
title_full Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma
title_fullStr Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma
title_full_unstemmed Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma
title_sort ral gef with the ph domain and sh3 binding motif 1 regulated by splicing factor junction plakoglobin and pyrimidine metabolism are prognostic in uterine carcinosarcoma
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/41a780605a324a9a8e54100709e540d9
work_keys_str_mv AT hongjunguo ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT siqiaowang ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT aiqingxie ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT wenhuizisun ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT chenluwei ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT shuyuanxian ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT huabinyin ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT mingxiaoli ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT hanlinsun ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT hongli ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT tongmeng ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT jiezhang ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
AT zongqianghuang ralgefwiththephdomainandsh3bindingmotif1regulatedbysplicingfactorjunctionplakoglobinandpyrimidinemetabolismareprognosticinuterinecarcinosarcoma
_version_ 1718442993142202368